Product Jurisdiction; Change of Address and Telephone Number; Technical Amendment

---
identifier: "/us/fr/2010-6246"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Product Jurisdiction; Change of Address and Telephone Number; Technical Amendment"
title_number: 0
title_name: "Federal Register"
section_number: "2010-6246"
section_name: "Product Jurisdiction; Change of Address and Telephone Number; Technical Amendment"
positive_law: false
currency: "2010-03-23"
last_updated: "2010-03-23"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2010-6246"
document_type: "rule"
publication_date: "2010-03-23"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
cfr_references:
  - "21 CFR Part 3"
fr_citation: "75 FR 13678"
fr_volume: 75
docket_ids:
  - "Docket No. FDA-2010-N-0010"
effective_date: "2010-04-19"
fr_action: "Final rule; technical amendment."
---


#  [Amended]

**Agency:**

Food and Drug Administration, HHS.

**Action:**

Final rule; technical amendment.

**SUMMARY:**

The Food and Drug Administration (FDA) is amending its regulations to reflect a change in the address and telephone number for the Office of Combination Products (OCP). This action is editorial in nature and is intended to improve the accuracy of the agency's regulations.

**DATES:**

Effective Date: April 19, 2010.

**FOR FURTHER INFORMATION CONTACT:**

John Barlow Weiner, Office of Combination Products, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 5130, Silver Spring, MD 20993-0002, 301-796-8930. To confirm that this change of address and telephone number has occurred, please see our Web site at *www.fda.gov/CombinationProducts/default.htm* .

**SUPPLEMENTARY INFORMATION:**

FDA is amending its regulations in 21 CFR part 3 to reflect a change in the address and telephone number for OCP. Publication of this document constitutes final action on this change under the Administrative Procedure Act (5 U.S.C. 553). Notice and public procedures are unnecessary because FDA is merely updating nonsubstantive content.

**List of Subjects in 21 CFR Part 3**

Administrative practice and procedure, Biologics, Combination products, Drugs, Medical devices.

**21 CFR Part 3**

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, 21 CFR part 3 is amended as follows:

**21 CFR Part 3**

**PART 3—PRODUCT JURISDICTION**

1. The authority citation for 21 CFR part 3 continues to read as follows:

**Authority:**

21 U.S.C. 321, 351, 353, 355, 360, 360c-360f, 360h-360j, 360gg-360ss, 360bbb-2, 371(a), 379e, 381, 394; 42 U.S.C. 216, 262, 264.

**21 CFR Part 3**

§ 3.6

2. Section 3.6 is amended by removing “(HFG-3), Food and Drug Administration, 15800 Crabbs Branch Way, suite 200, Rockville, MD 20855, 301-427-1934”and by adding in its place “Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 5129, Silver Spring, MD 20993-0002, 301-796-8930,”.

Dated: March 17, 2010.

Leslie Kux,

Acting Assistant Commissioner for Policy.